0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Update: photoradiation therapy for cancer

Tom Hager
JAMA. 1982;248(21):2795-2799. doi:10.1001/jama.1982.03330210005003.
Text Size: A A A
Published online

ABSTRACT

Complete remissions of early stage human lung and bladder cancers have been obtained with an experimental form of therapy called photoradiation therapy (PRT).

Researchers presenting the studies at the XIII International Cancer Conference in Seattle were enthusiastic about the treatment, entailing use of a photosensitizing agent activated by exposure to visible light. A dozen hospitals in the United States are already using this technique, and as many more are gearing up to do so.

But some investigators caution that results are still preliminary and that the treatment seems applicable only to a limited number of patients.

The key to the therapy is hematoporphyrin derivative (HpD), which "seems to have most of the qualities we want in a photosensitizing agent to treat cancer," according to Thomas J. Dougherty, PhD, of Roswell Park Memorial Institute in Buffalo, who has pioneered the development of the HpD system (JAMA [MEDICAL NEWS] 1979;242:403).

Three days

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();